Live Webinar

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Hosted by AJMC and Targeted Oncology

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
|Articles|October 1, 1996

The American Journal of Managed Care

  • October 1996
  • Volume 2
  • Issue 9

Use of a New Antiepileptic Drug in an HMO: Economic Outcomes from the Payer Perspective

Download PDF: Use of a New Antiepileptic Drug in an HMO: Economic Outcomes from the Payer Perspective

Articles in this issue

over 29 years ago

Estimating Prevalence and Detection Cost: Prerequisites for Disease State Management of Attention Deficit Hyperactivity Disorder

over 29 years ago

The Influence of New Devices on the Costs of Interventional Procedures

over 29 years ago

Patterns of Antidepressant Use and Their Relation to Costs of Care

over 29 years ago

Comparison of a Decision Analytic Model with Results from a Naturalistic Economic Clinical Trial: An Application to Evaluating Alternative Antidepressants

over 29 years ago

Comparison of a New Hand-Held Interactive Airway Monitoring System and a Conventional Peak Expiratory Flow Meter in the Management of Asthma

over 29 years ago

The Psychopharmacology of Depression in the Managed Care Setting

over 29 years ago

Cost-Effective Treatment of Depression

over 29 years ago

Correspondence regarding, "HEDIS 3.0: Advancing the State of the Art in Health Plan Performance Measurement"

Related Content